![[cordcorresp002.gif]](https://capedge.com/proxy/CORRESP/0001354488-09-000076/cordcorresp002.gif)
| |
United States Securities and Exchange Commission | January 23, 2009 |
Division of Corporate Finance | |
Mail Stop 3561 | |
Washington, D.C. 20549 | |
REQUEST FOR ACCELERATION OF EFFECTIVENESS
RE:
Cord Blood America, Inc. (the “Company”)
Registration Statement on Form S-1A (File No. 333-155882)
Filed December 2, 2008, and Amendments filed January 12, 2009 and January 23, 2009 (the “Registration Statement”)
We hereby request acceleration of the effective date of the Company’s pending Registration Statement to January 26, 2009, at 12:00 Noon Eastern Standard Time, or at the Commission’s earliest convenience.
We hereby acknowledge that:
should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;
the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
the Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
If you have any questions please contact me directly at 310.432.4090.
Sincerely
![[cordcorresp004.gif]](https://capedge.com/proxy/CORRESP/0001354488-09-000076/cordcorresp004.gif)
Matthew Schissler, CEO
501 Santa Monica Boulevard, Suite 700, Santa Monica, CA 90401
Ph: 310.432.4090; Fax: 310.432.4098